Replies to post #9919 on PharmaCyte Biotech Inc (PMCB)

[Lenny T]

This is what has caused all of the uproar!
A large portion of the report also focuses on the latest short squeeze data released by Buyins.net in April that "indicated the [NVLX] stock could move $2.00 higher." Kuhn concurs with that evaluation, stating "we could see a staircase climb to our 1st price target of $0.50 - $0.60" and "With a break above $0.875, the blood will be running off the tape due the predictive massive short squeeze, propelling the stock to our theoretical target of $1 - $2, matching Buyin.net's SS projection."

[Lenny T]

This was taked from the KonLin report that came out in May! This is a very good source for info!!

[NYC Trader]

IMO there is still more left. NVLX has been bullish for weeks, still some left? very possible....

[pingbag]

Yes, it should continue in an upward trend.